Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2026
Piramal Pharma completes acquisition of 40.67% incremental stake in Yapan Bio
Piramal Pharma Ltd. completed the acquisition of an incremental 40.67% stake in Hyderabad-based CDMO Yapan Bio Private Limited for an aggregate cash consideration of ₹76 crore ($7.95M), raising its ownership to 74% and making Yapan Bio a subsidiary.
2026
Piramal Pharma completes acquisition of controlling stake in Yapan Bio
Piramal Pharma Ltd. completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited for an aggregate cash consideration of ₹76 crore ($7.95M USD), bringing its ownership to 74% and making Yapan Bio a subsidiary.